Back to Search
Start Over
Osteogenesis Imperfecta Market is Expected to Expand at a Healthy Growth Rate by (2022-2032), States DelveInsight | Key Companies - Mereo BioPharm, Amgen Pharmaceuticals
- Source :
- M2 Presswire. November 10, 2022
- Publication Year :
- 2022
-
Abstract
- M2 PRESSWIRE-November 10, 2022-: Osteogenesis Imperfecta Market is Expected to Expand at a Healthy Growth Rate by (2022-2032), States DelveInsight | Key Companies - Mereo BioPharm, Amgen Pharmaceuticals (C)1994-2022 M2 [...]
- Subjects :
- Business -- Research
Denosumab -- Forecasts and trends -- Reports
BCG vaccines -- Growth -- Forecasts and trends -- Reports
Osteogenesis imperfecta -- Reports -- Forecasts and trends
BCG -- Growth -- Forecasts and trends -- Reports
Epidemiology -- Forecasts and trends -- Reports
Company growth
Market trend/market analysis
Business
Business, international
Subjects
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- M2 Presswire
- Publication Type :
- News
- Accession number :
- edsgcl.726002216